Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Positive results from Fasenra Phase II trial in hypereosinophilic syndrome published in New England Journal of Medicine
-
Selumetinib granted US Breakthrough Therapy Designation in neurofibromatosis type 1
-
Proposed placing of new ordinary shares
-
AstraZeneca and Daiichi Sankyo enter collaboration for novel HER2-targeting antibody-drug conjugate
-
Forxiga approved in Japan for type-1 diabetes
-
Forxiga approved in Europe for type-1 diabetes
-
First sub-analyses from the DECLARE-TIMI 58 trial further support the cardiovascular effects of Farxiga in type-2 diabetes
-
US FDA grants saracatinib Orphan Drug Designation for idiopathic pulmonary fibrosis
-
AstraZeneca showcases next-generation Oncology pipeline addressing unmet patient needs at AACR Annual Meeting
-
AstraZeneca to present new cardiovascular data on Farxiga in type-2 diabetes at ACC 2019
Latest articles and press releases
All of our latest press releases and articles are available to explore
